LABT · Lakewood-Amedex Biotherapeutics Inc.
$1.96
-0.08 (-3.92%)
At close · Jul 29
Going-concern doubt
— flagged May 22, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued has not been alleviated.”View the 10-Q filed May 22, 2026
Market Cap
$12.94M
Shares
7.00M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-04-24 | Tucker Joseph Edward |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Warrant to acquire Common Stock (Direct)
The warrants vest in four equal tranches of 8,446 warrants each on October 24, 2026, April 24, 2027, October 24, 2027, and April 24, 2028. |
Warrant to acquire Common Stock
|
33,784 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–1 of 1 transactions